Plasma medicine is a rapidly growing multidisciplinary field. Recently, experimental observations have shown that plasma-activated oil (PAO) with high reactive activity can effectively promote wound healing. In this study, a reactive molecular dynamic (MD) simulation is performed to investigate the interactions of reactive oxygen species (ROS), such as O, OH, and O 3 produced in atmospheric plasmas, and fatty acids in vegetable oils with the ReaxFF field. The reaction processes of the chemical bond breaking and formation of fatty acids upon impact by the ROS are deeply explored. The simulation shows that the reactions typically start with the H

No abstract

No abstract

Cancer immunotherapy, especially immune checkpoint therapy, has revolutionized therapeutic options by reactivating the host immune system. However, the efficacy varies, and only a small portion of patients develop sustained antitumor responses. Hence, illustrating novel strategies that improve the clinical outcome of immune checkpoint therapy is urgently needed. N6-methyladenosine (m6A) has been proved to be an efficient and dynamic posttranscriptional modification process. It is involved in numerous RNA processing, such as splicing, trafficking, translation and degradation. Compelling evidence emphasizes the paramount role of m6A modification in the regulation of immune response. These findings may provide a foundation for the rational combination of targeting m6A modification and immune checkpoints in cancer treatment. In the present review, we summarize the current landscape of m6A modification in RNA biology, and highlight the latest findings on the complex mechanisms by which m6A modification governs immune checkpoint molecules. Furthermore, given the critical role of m6A modification in antitumor immunity, we discuss the clinical significance of targeting m6A modification to improve the efficacy of immune checkpoint therapy for cancer control.